Loading...
Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures
The diuretic bumetanide failed to treat acute seizures due to hypoxic ischemic encephalopathy (HIE) in newborn babies and was associated with hearing loss (NEMO trial, Pressler et al., 2015). On the other hand, clinical and experimental observations suggest that the diuretic might provide novel ther...
Na minha lista:
| Udgivet i: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830840/ https://ncbi.nlm.nih.gov/pubmed/27147965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2016.00090 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|